Ecolab Stock: Now Attractive For Patient Investors (NYSE:ECL)

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

Almost two years ago, I recommended avoiding Ecolab (NYSE:ECL) due to its rich valuation back then. I specifically mentioned that the stock would probably incur a harsh landing if the 10-year Treasury yield kept rising. This

https://s24.q4cdn.com/931105847/files/doc_downloads/2022/11/Baird-11.8.2022-Final-for-Website.pdf

Ecolab Growth (Investor Presentation)

https://s24.q4cdn.com/931105847/files/doc_downloads/2022/11/Baird-11.8.2022-Final-for-Website.pdf

Ecolab’s Growing Addressable Market (Investor Presentation)

Be the first to comment

Leave a Reply

Your email address will not be published.


*